VAMP-5 inhibitors are a distinctive class of chemical compounds developed to target and inhibit the activity of VAMP-5, also known as Vesicle-Associated Membrane Protein 5. VAMP-5 is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein family, which is crucial for vesicular trafficking and membrane fusion processes within cells. This protein plays a role in the transport of vesicles between various intracellular compartments, including the Golgi apparatus, endosomes, and the plasma membrane. The inhibition of VAMP-5 affects the normal trafficking and fusion of these vesicles, which is essential for maintaining cellular function and homeostasis.
The mechanism of action of VAMP-5 inhibitors involves binding to the VAMP-5 protein and preventing its interaction with other SNARE proteins and components necessary for vesicle fusion. By obstructing these interactions, these inhibitors disrupt the vesicular transport machinery, which can lead to alterations in intracellular signaling, protein sorting, and overall cellular organization. Researchers employ VAMP-5 inhibitors to dissect the specific roles of VAMP-5 in vesicular trafficking and to explore how its inhibition affects various cellular processes. These studies provide valuable insights into the complex dynamics of intracellular transport and the contributions of VAMP-5 to cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
Alkylates thiols and can modify SNARE proteins, affecting their function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, potentially affecting vesicle scission and therefore SNARE-mediated vesicle fusion. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $25.00 $65.00 $170.00 $110.00 | 19 | |
Depletes cholesterol from membranes, possibly affecting SNARE-mediated membrane fusion. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts Golgi structure and function, which can affect vesicle formation and trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Disrupts Golgi pH gradient, which can affect protein sorting and trafficking. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting SNARE protein folding and function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits V-ATPase, potentially affecting vesicle acidification and neurotransmitter loading. | ||||||
Pitstop 2 | 1419093-54-1 | sc-507418 | 10 mg | $360.00 | ||
Inhibits clathrin-mediated endocytosis, potentially affecting the recycling of SNARE proteins. | ||||||